Small Bowel Transplantation

Small Bowel Transplantation

Small Bowel Transplantation

On this page

Indications & Contraindications - Gutless No More!

Indications (Irreversible Intestinal Failure):

  • Short Bowel Syndrome (SBS) - most common
    • Vascular catastrophe (e.g., midgut volvulus, mesenteric thrombosis)
    • Extensive Crohn's disease
    • Trauma
  • Intestinal dysmotility disorders
    • Chronic Intestinal Pseudo-obstruction (CIPO)
  • Congenital mucosal disorders (e.g., microvillus inclusion disease)
  • Recurrent TPN-related complications:
    • Progressive liver disease (TPN-associated cholestasis)
    • Recurrent central line sepsis (≥2/year or fungal)
    • Loss of venous access (≥2 major sites)
    • Severe dehydration/electrolyte imbalance despite TPN

Contraindications:

  • Absolute:
    • Active untreatable malignancy
    • Severe systemic infection (active sepsis)
    • Advanced irreversible multi-organ failure (severe cardiac/pulmonary/hepatic dysfunction not part of IF)
    • Active substance abuse, severe psychiatric illness, non-compliance
  • Relative:
    • HIV infection (case-by-case)
    • Advanced age (>60-65 years, physiological age more important)
    • Significant comorbidities

⭐ Most common indication for SBTx is Short Bowel Syndrome (SBS) secondary to vascular catastrophe in adults, and gastroschisis/intestinal atresia in children.

📌 Mnemonic for TPN complications leading to SBTx: LIVER

  • Liver disease (TPN-cholestasis)
  • Infections (recurrent line sepsis)
  • Venous access loss
  • Electrolyte/fluid imbalance (severe)
  • Renal impairment (less direct, but can be a factor with fluid issues)

Graft Types, Workup & Surgery - Match & Mend Guts

  • Graft Options:
    • Isolated Small Bowel Transplant (ISBTx)
    • Combined Liver-Small Bowel Transplant (LSBTx)
    • Multivisceral Transplant (MVT): Incl. stomach, pancreas, duodenum ± liver/colon.
  • Essential Workup:
    • Recipient:
      • Key Indication: Irreversible Intestinal Failure + severe Parenteral Nutrition (PN) Complications (e.g., IFALD, recurrent CVC sepsis, loss of access).
      • Matching: ABO, HLA typing, Panel Reactive Antibody (PRA) screen.
    • Donor:
      • ABO compatibility (identical/compatible).
      • Size matching (critical for abdominal domain). CMV status.
  • Surgical Cornerstones:
    • Vascular Anastomoses: Arterial (Aorta/SMA) & Venous (Portal vein).
    • Enteric Reconstruction: Proximal & distal bowel continuity.
    • Graft Monitoring: Ileostomy often created for endoscopic surveillance & biopsy.
    • Perioperative: Induction immunosuppression.

    ⭐ Short Gut Syndrome with Parenteral Nutrition failure is the leading indication for Small Bowel Transplantation (SBTx). Small bowel transplant graft types and anastomoses

Immunosuppression & Rejection - Immune Peace Talks

  • Goal: Prevent host immune destruction of graft.
  • Immunosuppression Phases:
    • Induction: Potent, short-term. Anti-thymocyte globulin (ATG), Basiliximab (IL-2R Ab).
    • Maintenance: Long-term triple therapy.
      • Calcineurin Inhibitors (CNIs): Tacrolimus (preferred), Cyclosporine.
      • Antiproliferatives: Mycophenolate Mofetil (MMF), Azathioprine.
      • Corticosteroids: Prednisolone.
    • 📌 Tacro, MMF, Steroids: Three Musketeers Stopping rejection.
  • Rejection Types & Management:
    • Hyperacute: Mins-hrs. Pre-formed Ab. Irreversible. Prevent: Crossmatch.
    • Acute Cellular Rejection (ACR): Days-wks. T-cell mediated. Dx: Biopsy. Rx: Steroid pulses; ATG (resistant).

      ⭐ ACR is most common, typically in first few months post-transplant.

    • Antibody-Mediated Rejection (AMR): Donor-Specific Antibodies (DSA). Dx: Biopsy (C4d+), DSA. Rx: Plasmapheresis, IVIG, Rituximab.
    • Chronic Rejection: Months-yrs. Fibrosis, gradual loss. Poor prognosis.
  • Small Bowel Specifics:
    • Highly immunogenic (↑Gut-Associated Lymphoid Tissue - GALT).
    • ↑ Rejection & Graft-versus-Host Disease (GVHD) risk.
    • Monitoring: Endoscopy + biopsy, serum citrulline.

Complications & Outcomes - Post-Tx Challenges

  • Rejection: Most significant challenge.
    • Acute Cellular Rejection (ACR): Commonest in first year; diagnosed by biopsy. Presents with fever, abdominal pain, ↑stoma output.
    • Chronic Rejection: Leads to fibrosis, dysmotility, malabsorption; major cause of late graft loss.
  • Infection: High risk due to potent immunosuppression.
    • Cytomegalovirus (CMV) is very common.
    • Bacterial, fungal, and other viral (e.g., EBV) infections are frequent.
  • Post-Transplant Lymphoproliferative Disorder (PTLD):
    • Often EBV-driven; incidence 10-20%.
    • Management: Reduce immunosuppression, rituximab.
  • Surgical Complications:
    • Anastomotic leak/stricture, bleeding, vascular thrombosis (arterial/venous).
  • Graft-versus-Host Disease (GVHD):
    • Less common than bone marrow transplant but carries high mortality.
  • Outcomes:
    • Patient Survival: 1-year ~75-80%; 5-year ~50-60%.
    • Graft Survival: 1-year ~70-75%; 5-year ~40-50%.
    • Successful transplant offers freedom from parenteral nutrition.

⭐ Acute cellular rejection remains the most common cause of graft dysfunction and loss in the first post-operative year for small bowel transplant recipients.

High‑Yield Points - ⚡ Biggest Takeaways

  • Key Indication: Short bowel syndrome with IFALD, recurrent line sepsis, or loss of vascular access.
  • Transplant Types: Isolated small bowel, combined liver-small bowel, or multivisceral grafts.
  • Potent immunosuppression (e.g., tacrolimus) is mandatory.
  • Acute cellular rejection is frequent; diagnosed by endoscopic biopsy.
  • High risk of CMV infection and PTLD (Post-Transplant Lymphoproliferative Disorder).
  • Graft-versus-host disease (GVHD) is a significant concern.
  • Regular endoscopic surveillance is crucial for graft monitoring.

Practice Questions: Small Bowel Transplantation

Test your understanding with these related questions

Match the following 1. Hirschsprung's disease 2. Posterior urethral valve 3. Choledochal cyst 4. Intussusception A. Jaundice B. Currant jelly stools C. Distended abdomen D. Oligohydramnios

1 of 5

Flashcards: Small Bowel Transplantation

1/9

Which kidney is taken during donor transplantation? Why? _____

TAP TO REVEAL ANSWER

Which kidney is taken during donor transplantation? Why? _____

Left

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial